公开(公告)号：US20070275952A1

公开(公告)日：2007-11-29

申请号：US10549300

申请日：2004-03-19

Applicant: Lynne Bannen ,  S. Brown ,  Wei Cheng ,  Vasu Jammalamadaka ,  John Nuss ,  Morrison Mac ,  Jason Parks ,  Matthew Williams ,  Wei Xu ,  Atwood Cheung ,  Lisa Dalrymple ,  Sergey Epshteyn ,  Mohamed Ibrahim ,  James Leahy ,  Gary Lewis ,  Robin Noguchi ,  Larry Mann ,  Brian Ridway ,  Joan Sangalang ,  Kevin Schnepp ,  Xian Shi ,  Richard Khoury

Inventor： Lynne Bannen ,  S. Brown ,  Wei Cheng ,  Vasu Jammalamadaka ,  John Nuss ,  Morrison Mac ,  Jason Parks ,  Matthew Williams ,  Wei Xu ,  Atwood Cheung ,  Lisa Dalrymple ,  Sergey Epshteyn ,  Mohamed Ibrahim ,  James Leahy ,  Gary Lewis ,  Robin Noguchi ,  Larry Mann ,  Brian Ridway ,  Joan Sangalang ,  Kevin Schnepp ,  Xian Shi ,  Richard Khoury

IPC: A61K31/41 ,  A61K31/44 ,  A61K31/445 ,  A61K31/497 ,  A61K31/535 ,  A61K31/551 ,  A61P35/00 ,  C07D243/08 ,  C07D285/10 ,  C07D401/14 ,  C07D413/00 ,  C07D417/02 ,  C12N5/00 ,  C12Q1/00

CPC classification number: A61K31/496 ,  C07D213/75 ,  C07D239/42 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D417/12 ,  C07D417/14

Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Tie-2. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.

Abstract translation: 本发明提供调节蛋白激酶酶活性以调节细胞活性如增殖，分化，程序性细胞死亡，迁移和化学侵蚀的化合物。 本发明的化合物抑制，调节和/或调节激酶，特别是Tie-2。 使用化合物及其药物组合物治疗激酶依赖性疾病和病症的方法也是本发明的一个方面。

公开(公告)号：US20070161651A1

公开(公告)日：2007-07-12

申请号：US10552426

申请日：2004-04-08

Applicant: Mohamed Ibrahim ,  James Leahy ,  Joan Sangalang ,  Kevin Schnepp ,  Xian Shi ,  John Nuss

Inventor： Mohamed Ibrahim ,  James Leahy ,  Joan Sangalang ,  Kevin Schnepp ,  Xian Shi ,  John Nuss

IPC: A61K31/517 ,  A61K31/506 ,  C07D403/04

CPC classification number: C07D239/94 ,  C07D401/04 ,  C07D405/04

Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Tie-2. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.

Abstract translation: 本发明提供调节蛋白激酶酶活性以调节细胞活性如增殖，分化，程序性细胞死亡，迁移和化学侵蚀的化合物。 本发明的化合物抑制，调节和/或调节激酶，特别是Tie-2。 使用化合物及其药物组合物治疗激酶依赖性疾病和病症的方法也是本发明的一个方面。

公开(公告)号：US20070208166A1

公开(公告)日：2007-09-06

申请号：US10576932

申请日：2004-10-22

Applicant: Deborah Baly ,  Adam Galan ,  Mohamed Ibrahim ,  Christopher Jaeger ,  Patrick Kearney ,  James Leahy ,  Gary Lewis ,  Kirk McMillan ,  Robin Noguchi ,  John Nuss ,  Jason Parks ,  Kevin Schnepp ,  Xian Shi ,  Matthew Williams ,  Wei Xu ,  Wentao Zhang

Inventor： Deborah Baly ,  Adam Galan ,  Mohamed Ibrahim ,  Christopher Jaeger ,  Patrick Kearney ,  James Leahy ,  Gary Lewis ,  Kirk McMillan ,  Robin Noguchi ,  John Nuss ,  Jason Parks ,  Kevin Schnepp ,  Xian Shi ,  Matthew Williams ,  Wei Xu ,  Wentao Zhang

IPC: C07D471/02

CPC classification number: C07C237/22 ,  C07C275/16 ,  C07C275/34 ,  C07C2602/10 ,  C07D207/16 ,  C07D209/20 ,  C07D209/42 ,  C07D209/44 ,  C07D213/56 ,  C07D213/75 ,  C07D215/48 ,  C07D215/54 ,  C07D217/06 ,  C07D217/22 ,  C07D233/56 ,  C07D233/58 ,  C07D263/32 ,  C07D277/46 ,  C07D277/66 ,  C07D277/82 ,  C07D295/155 ,  C07D295/185 ,  C07D319/20 ,  C07D401/04 ,  C07D401/12 ,  C07D405/12 ,  C07D413/12 ,  C07D471/04 ,  C07D495/04 ,  C07D513/04

Abstract: The invention provides compounds and methods for inhibition of kinases, such as those of the TAO family, more specifically KIAA1361, TAO, and JIK kinases. The invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinase receptor signal transduction pathways related to the changes in cellular activities as mentioned above, and the invention includes compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions.

Abstract translation: 本发明提供了用于抑制激酶的化合物和方法，例如TAO族的那些，更具体地是KIAA1361，TAO和JIK激酶。 本发明提供用于调节蛋白激酶酶活性以调节细胞活性如增殖，分化，程序性细胞死亡，迁移和化学侵蚀的化合物。 本发明的化合物抑制，调节和/或调节与上述细胞活性变化相关的激酶受体信号转导途径，本发明包括含有这些化合物的组合物，及其用于治疗激酶依赖性疾病和病症的方法 。